| Cat.No. | Name | Information |
|---|---|---|
| M2206 | TH-302 (Evofosfamide) | TH-302 is a highly potent and selective hypoxia-activated procompound targeting hypoxic regions of solid tumors with IC50 of 19 nM. |
| M6098 | Baicalein | Baicalein is a CYP2C9 and prolyl endopeptidase inhibitor, IC50 value of 3.12 mM. |
| M9325 | EGTA | EGTA is a specific calcium chelator with a Kd of 60.5 nM at physiological pH (7.4) and a high specificity for Ca2+ than for Mg2+.EGTA significantly inhibits the substrate adhesion capacity of inflammatory macrophages. |
| M9330 | Brij-35 | Brij-35 (Polidocanol) is a high HLB, ethoxylated, nonionic ether of lauryl alcohol with broad pH stability. |
| M6154 | 2-PMPA tetrasodium | 2-PMPA (PMPA tetrasodium salt) is a potent and selective inhibitor of glutamate carboxypeptidase II (GCPII) with an IC50 of 300 pM. |
| M2250 | Pamidronate disodium | Pamidronate disodium is a nitrogen containing bisphosphonate, used to the research of preventing osteoporosis. |
| M9916 | DPPH | DPPH (2,2-Diphenyl-1-picrylhydrazyl) is a stable free radical that measures the free radical scavenging activity of antioxidants. |
| M9194 | Insulin (human) | Insulin (human) is a polypeptide hormone that regulates the level of sugar (glucose) in the blood and is produced by beta cells of islets. |
| M3409 | Formestane | Formestane is a second generation selective aromatase inhibitor with an IC50 of 80 nM. |
| M9665 | N-(2-amino-2-oxoethyl)acrylamide | N-(2-Amino-2-oxoethyl)acrylamide |
| M50959 | Acetyl-PHF4 amide | Acetyl-PHF4 amide is a polypeptide that can be found by peptide screening. |
| M50958 | Ac-Pro-Leu-Gly-OH | Ac-Pro-Leu-Gly-OH is a polypeptide that can be found by peptide screening. |
| M50957 | Arginylisoleucine | Arginylisoleucine is a polypeptide that can be found by peptide screening. |
| M50956 | biotin-Bradykinin | biotin-Bradykinin is a biological active peptide. |
| M50955 | Boc-D-Trp(For)-OH | Boc-D-Trp(For)-OH, containing the amino acid tryptophan, is synthesized by the ammonolysis of Boc-protected D-alanine, followed by cyclization to form a dipeptide with ninhydrin. |
| M50954 | Calpain substrate | Calpain substrate is the membrane non-permeable fluorogenic calpain substrate and can be used in Calpain enzymatic activity assay. |
| M50953 | Cyclo(RGDfK(Mal)) | Cyclo(RGDfK(Mal)) is a pentapeptide. |
| M50952 | D-Ile-Phe-Lys-pNA | D-Ile-Phe-Lys-pNA is a highly specific substrate for human plasmin. |
| M50951 | D-Leu-Thr-Arg-pNA | D-Leu-Thr-Arg-pNA is a substrate for γ-Tryptase, and can be used to measure the effects of small molecule inhibitors on γ-Tryptase activity. |
| M50950 | D-Val-Leu-Arg-pNA | D-Val-Leu-Arg-pNA is a glandular kininoreleasing enzyme substrate that also acts as a substrate for tissue-type plasminogen activator (t-PA) with no apparent affinity for fibrin. |
| M50949 | D-Val-Leu-Lys-AMC | D-Val-Leu-Lys-AMC is a peptide substrate of plasmin. |
| M50948 | D-Val-Phe-Lys-CMK | D-Val-Phe-Lys-CMK (D-Val-Phe-Lys Chloromethyl ketone) can inhibit plasmin activity. |
| M50947 | F(N-Me)GA(N-Me)IL | F(N-Me)GA(N-Me)IL is a biological active peptide. |
| M50946 | Glycylglycinamide | Glycylglycinamide is a polypeptide that can be found by peptide screening. |
| M50945 | H-Gly-Gly-Arg-AMC | H-Gly-Gly-Arg-AMC is a fluorogenic peptidyl-AMC substrate containing C-terminal 7-amino-4-methylcoumarin (AMC). |
| M50944 | Histone H3 (1-20) | Histone H3 (1-20) is a polypeptide that can be found by peptide screening. |
| M50943 | Histone H3 (5-23) | Histone H3 (5-23), derived from histone H3 5-23 amino acids, can be used as a substrate for histone acetyltransferase (HAT) assays. |
| M50942 | H-Pro-Pro-Asp-NH2 | H-Pro-Pro-Asp-NH2 is a potent and selective catalyst for asymmetric aldol reactions. |
| M50941 | MAGE-A3 (195-203) | MAGE-A3 (195-203) is a human leukocyte antigen (HLA) -A24 molecules epitope encoded by melanoma antigen gene (MAGE). |
| M50940 | Neuromedin S(rat) | Neuromedin S(rat) is a 34-amino acids peptide from rat Neuromedin S. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
